Hosted on MSN40m
FDA Accepts J&J's Filing for Autoimmune Disease Drug NipocalimabJohnson & Johnson JNJ announced that the FDA has accepted its regulatory filing seeking the FDA’s approval for nipocalimab, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback